Skip to main content

Trusted Collaboration Environment: Revolutionizing Pharma’s Drug Development with Real-World Data

Trusted Collaboration Environment: Revolutionizing Pharma’s Drug Development with Real-World Data

In the rapidly evolving field of pharmaceuticals, secure, diverse, and global access to high-quality data is crucial for efficient and successful drug development. Traditional clinical trials have limitations, including cost, time, and a narrow patient population; to address these challenges, BC Platforms has introduced the Trusted Collaboration Environment (TCE), a cutting-edge federated analytics platform that leverages real-world data (RWD) to facilitate collaborative drug development in the pharmaceutical industry. Today our platform holds rich RWD from more than 50 million patient lives on 6 continents including North America, South America, Europe, Africa, Asia and Australia.

Let’s talk about how BC Platforms’ TCE can transform the drug development landscape:
BC Platforms TCE is an advanced cloud-based platform that enables global, secure and privacy-preserving collaboration between various stakeholders in the pharmaceutical industry, including pharmaceutical companies, academic institutions, research organizations, biobanks and healthcare providers. The platform integrates diverse and multi-omic and multi-modal datasets including genomic data, electronic health records (EHRs), claims data, (dicom) imaging and patient-reported outcomes (PROs), among others, to provide a comprehensive view of patients’ real-world experiences.

Now let’s share with you why unlocking the Power of Real-World Data (RWD) is important:
RWD refers to data collected from various sources outside of traditional clinical trials. It includes data from electronic health records, wearable devices, social media, and other sources. RWD provides insights into how drugs perform in real-world settings and offers a broader representation of patient populations. By harnessing the power of RWD, BC Platforms’ Trusted Collaboration Environment (TCE) allows pharmaceutical companies to overcome the limitations of traditional clinical trials and gain a deeper understanding of drug efficacy, safety, and patient outcomes all whilst adhering to the regulatory environments around the world.

What are the benefits of BC Platforms’ TCE in Drug Development?

  • Enhanced Study Design and Recruitment: Our unique TCE enables pharmaceutical companies to design more robust clinical studies by incorporating real-world evidence and leveraging a larger, global and diverse patient population. This leads to more accurate patient stratification and targeted recruitment, reducing the time and cost associated with traditional trials.
  • Improved Safety and Efficacy Assessment: By analyzing real-world data, BC Platforms’ TCE enables researchers to evaluate drug safety and efficacy in a more diverse patient population, including those with co-morbidities and other demographic factors. This comprehensive assessment ensures a more accurate understanding of a drug’s real-world performance.
  • Accelerated Time-to-Market: With a Trusted Collaboration Environment’s access to diverse real-world data, pharmaceutical companies can expedite the drug development process by identifying patient cohorts, biomarkers, and potential drug targets. This can lead to faster decision-making and quicker development of life-saving treatments.
  • Collaboration and Data Sharing: BC Platforms’ TCE promotes secure collaboration and data sharing among stakeholders. It enables researchers to collaborate on studies, share data, and access aggregated datasets while ensuring patient privacy and data security, without data movement or data copy. This collaborative approach fosters innovation and accelerates scientific discoveries.

BC Platforms’ Trusted Collaboration Environment can revolutionize the pharmaceutical industry’s drug development process by harnessing the power of real-world data swiftly and securely. By leveraging diverse datasets and enabling secure collaboration, a TCE provides pharmaceutical companies with a comprehensive view of patient experiences, leading to enhanced study design, improved safety and efficacy assessment, and accelerated time-to-market for life-saving drugs.

BC Platforms and our Data Partners have the data you did not think you could find!

Learn more